15 Best Growth Stocks to Invest in for the Next 5 Years

Page 5 of 13

9. Axogen, Inc. (NASDAQ:AXGN)

Upside potential as of June 24, 2025: 144.38%

On June 11, 2025, Axogen, Inc. (NASDAQ:AXGN) presented at the Goldman Sachs 46th Annual Global Healthcare Conference, where a strategic vision was highlighted that is focused on solidifying the company’s leadership in nerve repair solutions. The management remains confident about the giant’s position in delivering strong growth while expanding the product portfolio.

The company is undergoing a wave of transformative operational changes by adding new clinical application areas. With that being said, Axogen, Inc. (NASDAQ:AXGN) is working towards improving professional education activities and entering new areas.

The future outlook of Axogen, Inc. (NASDAQ:AXGN) looks equally promising. The company aims to expand internationally by 2026, with sustained investments in Avance and complementary products, targeting regeneration and protection devices. It doesn’t stop there; recognizing significant under-penetration in its existing markets, the company is committed to accelerating growth by advancing its commercial footprint and development initiatives.

Axogen, Inc. (NASDAQ:AXGN) is a Florida-based company that develops and markets technologies for peripheral nerve regeneration and repair worldwide. The company’s core offerings include Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector, AxoGuard Nerve Cap, and AxoGuard HA+ Nerve Protector. Founded in 2002, the company is focused on improving patients’ lives.

Page 5 of 13